GlassScriptPhysician profile
Robert S Rosen
NPI 1639187719
$1,899.71
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $731 · 2020: $51.78 · 2021: $112 · 2022: $232 · 2023: $255 · 2024: $518.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $314 · Gift: $162 · Food and Beverage: $158 · Travel and Lodging: $140.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $314.26 |
| Gift | $161.50 |
| Food and Beverage | $157.76 |
| Travel and Lodging | $139.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $355.94 | 2024 | |
| Smith+Nephew, INC. | $278.67 | 2019-2020 | |
| Ethicon US, LLC | $219.66 | 2019-2022 | |
| Braintree Laboratories, INC. | $204.06 | 2022-2023 | Sutab, Suflave |
| Carl Zeiss Meditec, INC. | $191.75 | 2019 | |
| Baxter Healthcare | $139.50 | 2024 | Perclot |
| Focal Therapeutics, INC. | $134.66 | 2019 | |
| W. L. Gore & Associates, INC. | $81.46 | 2019-2021 | |
| Kerecis Limited | $42.66 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Pacira Pharmaceuticals Incorporated | $35.43 | 2019-2021 | |
| Baudax Bio INC. | $23.46 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $22.87 | 2024 | |
| Organogenesis INC. | $21.55 | 2023 | Puraply |
| Osiris Therapeutics INC. | $20.92 | 2019 | |
| Zyla Life Sciences, INC. | $19.67 | 2020 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tela Bio, INC. | $17.72 | 2022 | |
| Heron Therapeutics, INC. | $17.46 | 2021 | |
| Therapeuticsmd, INC. | $16.54 | 2021 | |
| Novo Nordisk INC | $16.40 | 2019 | |
| Innocoll Pharmaceuticals Limited | $14.37 | 2021 | |
| Amgen INC. | $13.17 | 2022 | |
| Medtronic, INC. | $11.79 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Rosen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.